ALISON TAUNTON-RIGBY - Corporate Board Profile

TRI-CONTINENTAL Corp

Filing Date	Source Excerpt
2008-08-22	Alison Taunton-Rigby (64) 901 S. Marquette Ave., Minneapolis, MN 55402; 2008-2009; N/A; Chief Executive Officer, RiboNovix, Inc. since 2003; former President, Forester Biotech; Director of RiverSource funds since 2002; Director of Healthways, Inc., Idera Pharmaceuticals, Inc., Abt Associates, Inc. and the Children’s Hospital of Boston; Director/Trustee of the Biomedical, Science Careers Program, the Mass Women’s Forum, the Whitehead Institute and Bentley College Business Ethics Board.
2009-04-09	Alison Taunton-Rigby 901 Marquette Ave. South Minneapolis, MN 55402 Age 64 2009-2012; Board member since November 7, 2008 Chief Executive Officer and Director, RiboNovix, Inc. since 2003 (biotechnology); former President, Forester Biotech IderaPharmaceuticals, Inc. (biotechnology); Healthways, Inc. (health management programs); other funds in the RiverSource Family of Funds Contracts, Distribution, Executive, Investment Review
2011-02-18	Alison Taunton-Rigby 901 Marquette Ave. South Minneapolis, MN 55402 Age 66 2009-2012; Board member since November 2008 Chief Executive Officer and Director, RiboNovix, Inc. since 2003 (biotechnology); former President, Aquila Biopharmaceuticals Idera Pharmaceuticals, Inc. (biotechnology); Healthways, Inc. (health management programs); other funds in the Columbia Family of Funds Contracts, Executive, Investment Review Total Compensation From Corporation and Columbia Family of Funds: $2,223.02 + $198,727.42 = $200,950.44
2012-02-28	Alison Taunton-Rigby901 Marquette Ave. South Minneapolis, MN 55402Age 67 2012-2015;Board membersince November2008 Chief Executive Officerand Director,RiboNovix, Inc. 2003-2010 (biotechnology);former President, AquilaBiopharmaceuticals Director, Healthways,Inc. (health managementprograms); Director ICIMutual InsuranceCompany RRG;Director, Abt Associates(government contractor);other funds in theColumbia Family ofFunds Contracts, Executive,Investment Review Total Compensation From Corporation and Columbia Family of Funds* $227,833
2013-02-25	Alison Taunton-Rigby 1944; 2012-2015; Board member since November 2008; CEO and Director, RiboNovix, Inc. 2003-2010; Committees: Audit, Executive, Investment Review; Compensation: $255,000.
2015-03-04	Alison Taunton-Rigby 901 S. Marquette Ave. Minneapolis, MN 55402 1944 2015-2018; Board member since November 2008 Managing Director, Forester Biotech (consulting) since 2001; Chief Executive Officer and Director, RiboNovix, Inc. (biotechnology), 2003-2010; President and Chief Executive Officer of CMT Inc., 2001-2003; Aquila Biopharmaceuticals Inc., 1996-2000; Cambridge Biotech Corporation, 1995-1996; Mitotix Inc., 1993-1994 Director, Healthways, Inc. (health and well-being solutions) since 2005; Director, ICI Mutual Insurance Company since 2011; Director, Abt Associates (government contractor) since 2001; Director, Boston Childrens Hospital since 2002; other funds in the Columbia Family of Funds since 2002 Audit,BoardGovernance,InvestmentReview Total Compensation From Corporation and Columbia Family of Funds $270,000
2016-03-15	Alison Taunton-Rigby 1944 2015-2018; Director since November 2008 Managing Director, Forester Biotech (consulting), 2001-2003; Chief Executive Officer and Director, RiboNovix, Inc., (biotechnology), 2003-2010; President and Chief Executive Officer of CMT Inc., 2001-2003; Aquila Biopharmaceuticals Inc., 1996-2000; Cambridge Biotech Corporation, 1995-1996; Mitotix Inc., 1993-1994 Director, Abt Associates (government contractor) since 2001; Director, Boston Children’s Hospital since 2002; Director, Healthways, Inc. (health and well-being solutions) since 2005; Director, ICI Mutual Insurance Company, since 2011 BoardGovernance,Audit,InvestmentReview Total Compensation From Corporation and Columbia Family of Funds: $295,000
2017-03-08	Alison Taunton-Rigby 1944 2015-2018 Director since November 2008 President, Chief Executive Officer (CEO) and Director, RiboNovix, Inc., 2003-2010; President and CEO, CMT Inc., 2001-2003; President and CEO, Aquila Biopharmaceuticals Inc., 1997-2000; President and CEO, Cambridge Biotechnology Corporation, 1995-1997; President and CEO, Mitotix Inc., 1993-1994 Trustee to other Columbia Funds since 2002; Director, Boston Children’s Hospital since 2002; Director, ICI Mutual Insurance Company, since 2011; Director, Blumont/IRD since 2016; Director, Mount Ida College since 2016; former Director, Abt Associates (government contractor) 2001-2006; former Director, Healthways, Inc. (health and well-being solutions), 2005-2016 Audit,Board Governance,Contracts,Investment Review ... The attendance, retainer, committee and/or sub-committee fees paid to a current Director of the Corporation and from all funds in the Columbia Funds Complex (in their capacity as director/trustee of such funds) during the year ended December 31, 2016 was as follows: Alison Taunton-Rigby 6,726 0 305,000